Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management.

177Lu-PSMA-617 Radioligand therapy Salivary gland dysfunction Xerostomia

Journal

Translational oncology
ISSN: 1936-5233
Titre abrégé: Transl Oncol
Pays: United States
ID NLM: 101472619

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 17 03 2022
revised: 11 04 2022
accepted: 26 04 2022
pubmed: 7 5 2022
medline: 7 5 2022
entrez: 6 5 2022
Statut: ppublish

Résumé

Prostate specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed on prostate epithelial cells and is strongly upregulated in prostate cancer. Radioligand therapy using beta-emitting Lutetium-177 (

Identifiants

pubmed: 35523007
pii: S1936-5233(22)00104-8
doi: 10.1016/j.tranon.2022.101445
pmc: PMC9079342
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101445

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Références

Nucl Med Commun. 1998 Feb;19(2):183-4
pubmed: 9548203
Community Dent Health. 1999 Mar;16(1):12-7
pubmed: 10697349
Nucl Med Commun. 2022 Feb 1;43(2):166-171
pubmed: 34864811
Nucl Med Commun. 1996 Aug;17(8):681-6
pubmed: 8878127
Clin Otolaryngol. 2009 Aug;34(4):358-63
pubmed: 19673984
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):581-592
pubmed: 29678523
Nuklearmedizin. 2014 Aug 6;53(4):139-45
pubmed: 24569818
Nucl Med Commun. 2017 Jan;38(1):91-98
pubmed: 27782913
Oral Surg Oral Med Oral Pathol. 1993 Apr;75(4):466-71
pubmed: 8464611
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Mar;91(3):311-6
pubmed: 11250628
Oral Dis. 2011 Jan;17(1):109-14
pubmed: 21029258
Nucl Med Biol. 2021 Jul-Aug;98-99:30-39
pubmed: 34020337
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 May;125(5):478-486
pubmed: 29523427
Nucl Med Mol Imaging. 2018 Feb;52(1):80-81
pubmed: 29391917
J Nucl Med. 2016 Jul;57(7):1006-13
pubmed: 26795286
J Nucl Med Technol. 2003 Jun;31(2):81-5
pubmed: 12777459
Curr Oncol. 2021 Sep 23;28(5):3692-3704
pubmed: 34590608
J Clin Diagn Res. 2016 Jan;10(1):ZC60-2
pubmed: 26894178
J Ultrasound Med. 2020 Sep;39(9):1811-1818
pubmed: 32309884
Oral Dis. 2007 Jan;13(1):88-92
pubmed: 17241436
Oncotarget. 2017 Jan 10;8(2):3581-3590
pubmed: 27683041
JAMA. 1971 Jun 28;216(13):2109-16
pubmed: 4932139
J Nucl Med. 2019 Apr;60(4):517-523
pubmed: 30291192
Oncotarget. 2016 Mar 15;7(11):12477-88
pubmed: 26871285
Pharmaceuticals (Basel). 2019 Jan 24;12(1):
pubmed: 30678341
Gerodontology. 2010 Jun;27(2):129-33
pubmed: 20337727
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
Clin Nucl Med. 2020 Jan;45(1):19-31
pubmed: 31789908
Nucl Med Commun. 2006 Jun;27(6):495-9
pubmed: 16710103
Lancet. 2021 Feb 27;397(10276):797-804
pubmed: 33581798
J Am Dent Assoc. 1987 Oct;115(4):581-4
pubmed: 3477595
EJNMMI Res. 2018 Jul 3;8(1):56
pubmed: 29971556
Int Ser Monogr Oral Biol. 1964;3:177-95
pubmed: 14170722
J Urol. 2016 Aug;196(2):382-91
pubmed: 26964917
Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):449-53
pubmed: 20056347
J Nucl Med Technol. 2009 Mar;37(1):1-13
pubmed: 19223429
Mol Imaging. 2020 Jan-Dec;19:1536012120934992
pubmed: 32619138
EJNMMI Res. 2015 Dec;5(1):114
pubmed: 26099227
Ann Nucl Med. 2003 Dec;17(8):627-31
pubmed: 14971603
J Nucl Med. 2018 Dec;59(12):1865-1868
pubmed: 30097503
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1976-83
pubmed: 26227531
J Nucl Med. 2018 May;59(5):747-748
pubmed: 29439016
Oral Dis. 2002 Mar;8(2):77-89
pubmed: 11991308
Clin Physiol Funct Imaging. 2016 Jan;36(1):1-10
pubmed: 25319072
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):42-51
pubmed: 26318602
Clin Nucl Med. 2002 Nov;27(11):767-71
pubmed: 12394122
Acta Otorhinolaryngol Ital. 2017 Apr;37(2):155-159
pubmed: 28516979
Clin Rheumatol. 2021 May;40(5):1923-1931
pubmed: 33074391
J Nucl Med. 2017 Jan;58(1):85-90
pubmed: 27765862
Arch Oral Biol. 1969 Jun;14(6):591-6
pubmed: 5257932
Molecules. 2019 Feb 11;24(3):
pubmed: 30754620
Br J Radiol. 2022 Feb 01;95(1130):20210718
pubmed: 34928174
Clin Oncol (R Coll Radiol). 2007 Feb;19(1):83-6
pubmed: 17305259
J Clin Diagn Res. 2017 Aug;11(8):TC23-TC28
pubmed: 28969240
J Clin Invest. 1987 May;79(5):1310-3
pubmed: 3033020
Ann N Y Acad Sci. 1993 Sep 20;694:72-7
pubmed: 8215087
J Nucl Med. 2016 Aug;57(8):1170-6
pubmed: 26985056
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1187-94
pubmed: 15990024
J Nucl Med. 2019 Sep;60(9):1270-1276
pubmed: 30737300
J Nucl Med. 1984 Jul;25(7):755-8
pubmed: 6737074
Swed Dent J. 1983;7(6):227-38
pubmed: 6583873
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2642-2651
pubmed: 33495926
J Nucl Med Technol. 1999 Mar;27(1):20-6
pubmed: 10322570
Clin Nucl Med. 2016 Jul;41(7):522-8
pubmed: 27088387
Drugs. 1995 Jan;49(1):143-55
pubmed: 7705213

Auteurs

Sonia Mahajan (S)

Nuclear Medicine, Department of Radiology, New York University Grossman School of Medicine, New York, NY, United States of America. Electronic address: sonia.mahajan@nyulangone.org.

Ravinder K Grewal (RK)

Molecular Imaging & Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.

Kent P Friedman (KP)

Nuclear Medicine, Department of Radiology, New York University Grossman School of Medicine, New York, NY, United States of America; Molecular Imaging & Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.

Heiko Schöder (H)

Molecular Imaging & Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.

Neeta Pandit-Taskar (N)

Molecular Imaging & Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.

Classifications MeSH